Skip to main content
. Author manuscript; available in PMC: 2014 Apr 15.
Published in final edited form as: Clin Cancer Res. 2013 Feb 26;19(8):2257–2264. doi: 10.1158/1078-0432.CCR-12-3476

Figure 1.

Figure 1

Waterfall plot showing best overall. Each bar represents an individual patient. The low pAKT cohort is shown on the left; the high pAKT cohort is shown on the right. Hatched bars show patients who experienced tumor shrinkage of at least 25%. All melanomas had a BRAFV600E mutation except for two patients who had melanomas with a BRAFV600K mutation (indicated by K) and one patient who had a melanoma with a NRASQ61K mutation (as indicated).